Health
Havas Health & You Launches Dynamic Value and Access Consultancy, Archipelago
NEW YORK, March 9, 2023 /PRNewswire/ -- The success of life sciences brands depends on their ability to navigate complexities around value, access, pricing, and reimbursement. To help clients solve for these issues, Havas Health & You publicly announced the launch of its first standalone value an...
2023-03-09 22:15
2582
Chamlion, the world's first dental 3D printing service cloud platform will appear at the IDS
COLOGNE, Germany, March 9, 2023 /PRNewswire/ -- On March 14, Chamlion, a digital dental expert, will appear at the IDS inGermany, exhibiting the world's first dental 3D printing service cloud platform at booth K091 in Hall 11.3, providing one-stop solutions for global dental processing customers....
2023-03-09 22:00
2128
Medit Launches New Occlusion Analyzer App for Quick and Easy Analysis
SEOUL, South Korea and LONG BEACH, Calif., March 9, 2023 /PRNewswire/ -- Medit (
www.medit.com
2023-03-09 21:00
2326
Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-Regional Partnership to Commercialize RNAi Therapeutics
ZUG, Switzerland, March 9, 2023 /PRNewswire/ -- Alnylam Pharmaceuticals, Inc.
2023-03-09 20:01
2365
Waterdrop Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 17, 2023
BEIJING, March 9, 2023 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it will report its unaudited financial results for the fourth quarter a...
2023-03-09 19:45
2976
GenFleet Therapeutics to Present Phase I Data for GFH312 at 2023 American Society for Clinical Pharmacology & Therapeutics Meeting
SHANGHAI, March 9, 2023 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the results from phase I study of GFH312 (RIPK1 inhibitor) monotherapy will be presented as a poster at the 2023 ASC...
2023-03-09 19:00
1569
World-First, 45,000 patients study to develop AI-based "precision medicine" for migraine relief - collaboration between Healint and University of Geneva, Switzerland
PALO ALTO, Calif., March 9, 2023 /PRNewswire/ -- Healint, the developer and
owner of Migraine Buddy – the world's largest migraine tracking and research
platform used by more than 3 million people – is announcing a collaboration
with the University ofGeneva.
2023-03-09 16:55
1653
NIPPON EXPRESS HOLDINGS Strengthens Pharmaceutical Logistics Quality System Globally
- Compiles "NX-Pharma Global Quality Manual" and Appoints Head of NX-Pharma Global Quality - TOKYO, March 9, 2023 /PRNewswire/ -- NIPPON EXPRESS HOLDINGS, INC., based in Tokyo, has compiled the NX-Pharma Global Quality Manual, applicable as of Sunday, January 1, 2023, to unify and standardize ph...
2023-03-09 14:57
2296
Servier Announces Partnership with QIAGEN to Develop New mIDH1 Companion Diagnostic Test to Support Servier's Onco-hematology Portfolio
PARIS, March 9, 2023 /PRNewswire/ -- Servier, a global pharmaceutical group, today announced it has entered into a strategic partnership with QIAGEN, a leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the buil...
2023-03-09 14:30
1606
GRAND LAUNCHING OF DNATEST.ID, A COMPREHENSIVE DNA TEST IN INDONESIA
JAKARTA, Indonesia, March 9, 2023 /PRNewswire/ -- PT Henindo Technologies Citra Mulia (HENINDO) together with PT Regene Artifisial Inteligen (REGENE) announce the launching of a comprehensive DNA TEST under the brand name of DNAtest.id. The event was attended byProf. Dr. Amien Soebandrio, PhD, Sp...
2023-03-09 10:00
2641
DIGITAL THERAPEUTICS STARTUP RESPIREE™ GAINS US FDA CLEARANCE FOR ITS RS001 CARDIO-RESPIRATORY WEARABLE
SINGAPORE, March 9, 2023 /PRNewswire/ -- Digital therapeutics startup Respiree
2023-03-09 08:14
6000
Estrella Biopharma Announces FDA Clearance of IND Application for Phase I/II Clinical Trial (Starlight-1) of EB103, a CD19-Targeted ARTEMIS® T Cell Therapy, to Patients with B-Cell Lymphomas
Initiation of Phase I/II Clinical Trial (Starlight-1) Expected to Occur in Second Half of 2023 EMERYVILLE, Calif. and NEW YORK, March 8, 2023 /PRNewswire/ -- Estrella Biopharma, Inc. ("Estrella"), a biopharmaceutical company whose mission is to harness the evolutionary power of the human immune ...
2023-03-09 05:15
1932
Mallinckrodt Announces Reimbursement Approval in Japan for the CELLEX® Extracorporeal Photopheresis (ECP) System for the Treatment of Chronic Graft Versus Host Disease (cGvHD)
– CELLEX ECP is now available for reimbursement in Japan for patients who are steroid-resistant or -intolerant and suffering from cGvHD – DUBLIN, March 9, 2023 /PRNewswire/ -- Mallinckrodt plc, (NYSE American: MNK) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, tod...
2023-03-09 05:00
2149
Telix to Showcase Additional ZIRCON Phase III Data in Kidney Cancer Imaging and Theranostic Pipeline Developments at EAU
MELBOURNE, Australia, March 9, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations from the Company's carbonic anhydrase IX (CAIX) targeting kidney and bladder cancer programs at the 38th Annual European Association of Urology (EAU) Cong...
2023-03-09 04:51
2304
ETAO International Entered Into Standby Equity Purchase Agreement of Up To $150 Million with YA II PN, Ltd.
NEW YORK, March 9, 2023 /PRNewswire/ -- ETAO International Co., Ltd. ("ETAO" or the "Company") announced onFebruary 24, 2023, ETAO and YA II PN, Ltd., a Cayman Islands exempt limited partnership (the "Investor") managed by Yorkville Advisors Global, LP (the "Investment Manager"), entered into a S...
2023-03-09 02:21
2471
Decipher Fat Burning: A Breath Analyzer Achieved Funding Goal on Indiegogo in 1 Hour
SINGAPORE, March 8, 2023 /PRNewswire/ -- Singapore-based Tech startup Metanoia Sensing has announced a new breath analyzer 'MetaNose' to help people monitor their fat (lipid) burning status. The device also provides insights into the users' metabolic health risk such as diabetic related condition...
2023-03-09 00:00
2057
BIORCHESTRA Participating in Two Upcoming Therapeutic RNA-Focused Events
CAMBRIDGE, Mass. and DAEJEON, South Korea, March 8, 2023 /PRNewswire/ --
BIORCHESTRA
2023-03-08 22:47
1828
Hovione receives the 2023 CDMO Leadership Award in all six categories and is Champion in Compatibility and Expertise
LISBON, Portugal, March 8, 2023 /PRNewswire/ -- Hovione, the leader in spray
drying and particle engineering, won the2023 CDMO Leadership Award
2023-03-08 22:00
1976
JW Therapeutics Announces Initiation of Clinical Study of Carteyva® in First-line Treatment in Patients with High-Risk Large B-Cell Lymphoma
SHANGHAI, March 8, 2023 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the initiation of clinical study of Carteyva® (relmacabtagene autoleucel inje...
2023-03-08 17:30
3093
IVI launches global study to determine the burden of HPV among girls and women
SEOUL, South Korea, March 8, 2023 /PRNewswire/ -- The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, announced the start of a multi-country study to better understand...
2023-03-08 16:40
1851
Week's Top Stories
Most Reposted
Thailand Tops 2024 Consumer Review Awards by Agoda
[Picked up by 329 media titles]
2024-09-26 11:00
WARHAMMER 40,000: SPACE MARINE VR - DEFENDERS OF AVARAX NOW AVAILABLE AT ZERO LATENCY VR VENUES WORLDWIDE
[Picked up by 314 media titles]
2024-09-26 00:00
Advantech Unveils Expanded Singapore Office to Boost ASEAN Presence and Support AIoT Innovations with Strategic Partnerships
[Picked up by 312 media titles]
2024-09-23 13:37
Circles Partners with Telkomsel, Providing an Advanced Software-as-a-Service (SaaS) Platform to Enhance Customer Digital Experience
[Picked up by 299 media titles]
2024-09-27 10:00RuggON Debuts at the Largest Mining Expo, MINExpo 2024 Showcasing Rugged Solutions for the Trillion-Dollar Mining Market
[Picked up by 294 media titles]
2024-09-23 22:00
Most Read
WARHAMMER 40,000: SPACE MARINE VR - DEFENDERS OF AVARAX NOW AVAILABLE AT ZERO LATENCY VR VENUES WORLDWIDE
2024-09-26 00:00
9378
Thailand Tops 2024 Consumer Review Awards by Agoda
2024-09-26 11:00
8261
RuggON Debuts at the Largest Mining Expo, MINExpo 2024 Showcasing Rugged Solutions for the Trillion-Dollar Mining Market
2024-09-23 22:00
6954